Figure 2.

Genetic testing resulted in a new diagnosis in nearly 50% of patients tested in the first year (N=9/19). All samples were sent for commercial gene panel testing. Inconclusive results consisted of variants of uncertain significance, or a single heterozygous variant in a recessive disease gene. Cleared to donate is a subset of the no pathogenic variant identified category.